Prostate cancer screening was revolutionized in the early 1990s with the wide spread availability and FDA approval of PSA testing. PSA however is not specific for clinically significant prostate ...

A prostate biopsy involves removing prostate tissue to test for cancer. Learn about types, procedure, risks, and follow-up ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

In a study involving more than 11,000 men enrolled in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial, about one quarter of elevated prostate-specific antigen (PSA) results ...

Current prostate specific antigen (PSA) testing "may not effectively target testing to those most likely to benefit, raising concerns about overtesting" warn researchers from the University of Oxford ...

To date, men undergoing screening through the measurement of prostate-specific antigen (PSA) levels have had a significant reduction in neoplastic mortality. Because of its low specificity, however, ...

The risk difference for the group randomized to the screening invitation compared with the control group who were not invited to undergo screening was 0.11% (95% CI 0.03-0.20) for low-grade cancer and ...

PSA Test: People in India do not get tested easily, even if they have a disease. Talking about regular testing is meaningless. But doctors warn that every man should get a PSA test done once after ...

Share on Pinterest Scientists are working on developing a urine test to detect prostate cancer. Anchalee Phanmaha/Getty Images Early detection of prostate cancer remains a major clinical challenge due ...

NEW YORK (Reuters Health) - Men who are 75-80 years old and have a low prostate specific antigen (PSA) level -- that is, less than less than 3 nanograms per milliliter -- are unlikely to develop ...

Has Joe Biden ever had a prostate-specific antigen or PSA test? It’s a simple blood draw that measures a protein potentially indicating prostate cancer and is nearly always included in a middle-aged ...